X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (25) 25
female (21) 21
index medicus (20) 20
oncology (19) 19
aged (17) 17
male (16) 16
middle aged (16) 16
seer program (14) 14
united states - epidemiology (14) 14
adult (12) 12
breast cancer (12) 12
cancer (12) 12
incidence (11) 11
survival (11) 11
public, environmental & occupational health (10) 10
women (9) 9
aged, 80 and over (8) 8
epidemiology (8) 8
survival rate (8) 8
article (7) 7
breast neoplasms - epidemiology (7) 7
neoplasm staging (7) 7
prognosis (7) 7
trends (7) 7
united-states (7) 7
diagnosis (6) 6
research (6) 6
survival analysis (6) 6
abridged index medicus (5) 5
biomarkers (5) 5
estrogen (5) 5
rates (5) 5
risk factors (5) 5
african americans - statistics & numerical data (4) 4
age factors (4) 4
breast neoplasms - mortality (4) 4
chemotherapy (4) 4
health aspects (4) 4
mortality (4) 4
neoplasms - epidemiology (4) 4
population (4) 4
registries (4) 4
risk (4) 4
statistics (4) 4
surveillance (4) 4
age distribution (3) 3
analysis (3) 3
breast neoplasms - metabolism (3) 3
breast-cancer (3) 3
care and treatment (3) 3
cause of death (3) 3
cohort studies (3) 3
colorectal cancer (3) 3
demographic aspects (3) 3
european continental ancestry group - statistics & numerical data (3) 3
health risk assessment (3) 3
hormones (3) 3
lung-cancer (3) 3
lymphoma, large b-cell, diffuse - mortality (3) 3
men (3) 3
neoplasms - mortality (3) 3
recommendations (3) 3
retrospective studies (3) 3
risk assessment (3) 3
seer program - statistics & numerical data (3) 3
thyroid-cancer (3) 3
treatment outcome (3) 3
trial (3) 3
tumors (3) 3
united states (3) 3
womens health (3) 3
american society (2) 2
and end results (2) 2
b-cell lymphoma (2) 2
biomarkers, tumor - metabolism (2) 2
breast (2) 2
breast neoplasms - diagnosis (2) 2
breast neoplasms - ethnology (2) 2
breast neoplasms - pathology (2) 2
bronchus (2) 2
cancer patients (2) 2
changing incidence (2) 2
colon (2) 2
colorectal neoplasms - mortality (2) 2
comorbidity (2) 2
confounding factors (2) 2
data interpretation, statistical (2) 2
demographics (2) 2
elderly-patients (2) 2
erbb-2 protein (2) 2
expression (2) 2
follow-up studies (2) 2
guidelines (2) 2
health maintenance organizations (2) 2
hispanic americans - statistics & numerical data (2) 2
incidence rates (2) 2
increasing incidence (2) 2
lung neoplasms - drug therapy (2) 2
medicare (2) 2
missing data (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer, ISSN 0008-543X, 07/2018, Volume 124, Issue 13, pp. 2785 - 2800
BACKGROUND The American Cancer Society (ACS), the Centers for Disease Control and Prevention (CDC), the National Cancer Institute (NCI), and the North American... 
North American Association of Central Cancer Registries (NAACCR) | Surveillance | survival | mortality | National Program of Cancer Registries (NPCR) | cancer | and End Results (SEER) | Annual Report to the Nation | incidence | Epidemiology | trends | National Vital Statistics System (NVSS) | UNITED-STATES | INCREASING INCIDENCE | SURVEILLANCE DATA | HUMAN-PAPILLOMAVIRUS | FEATURING CANCERS | SPECIAL SECTION | CIGARETTE-SMOKING | ONCOLOGY | COLORECTAL-CANCER | THYROID-CANCER | PROSTATE-CANCER | United States - epidemiology | Humans | Male | Incidence | Preventive Health Services - statistics & numerical data | American Cancer Society | Censuses | Sex Factors | Survival Analysis | Cause of Death - trends | Female | SEER Program - statistics & numerical data | Neoplasm Staging | Neoplasms - pathology | National Cancer Institute (U.S.) - statistics & numerical data | Neoplasms - epidemiology | Brain | Liver | Colorectal carcinoma | Lung cancer | Nervous system | Colon cancer | Uterus | Race | Children | Colon | Trends | Pancreas | Vital statistics | Women | Statistical analysis | Mortality | Melanoma | Bronchus | Breast cancer | Minority & ethnic groups | Statistics | Survival | Pharynx | Disease control | Oral cavity | Ethnicity | Men | Rectum | Breast | Death | Skin | Health risk assessment | Prostate | Cancer | Original
Journal Article
Cancer Epidemiology Biomarkers and Prevention, ISSN 1055-9965, 06/2018, Volume 27, Issue 6, pp. 619 - 626
Journal Article
Cancer Epidemiology Biomarkers and Prevention, ISSN 1055-9965, 05/2011, Volume 20, Issue 5, pp. 733 - 739
Journal Article
Statistics in Medicine, ISSN 0277-6715, 03/2017, Volume 36, Issue 6, pp. 1014 - 1028
Journal Article
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, ISSN 1055-9965, 09/2019, Volume 28, Issue 9, pp. 1544 - 1551
We investigated differences in net cancer survival (survival observed if the only possible cause of death was the cancer under study) estimated using new... 
Journal Article
Journal of the National Cancer Institute Monographs, ISSN 1052-6773, 11/2014, Volume 2014, Issue 49, pp. 255 - 264
Background To isolate progress against cancer from changes in competing causes of death, population cancer registries have traditionally reported cancer... 
Colonic Neoplasms - mortality | SEER Program | Prognosis | Age Factors | Risk Assessment | Comorbidity | Lung Neoplasms - mortality | United States | Humans | Middle Aged | Male | Survival Rate | Cause of Death | Prostatic Neoplasms - mortality | Young Adult | Aged, 80 and over | Adult | Breast Neoplasms - mortality | Female | Aged | Neoplasm Staging
Journal Article
Cancer, ISSN 0008-543X, 09/2017, Volume 123, Issue 17, pp. 3326 - 3334
BACKGROUND Survival after the diagnosis of diffuse large B‐cell lymphoma (DLBCL) has been increasing since 2002 because of improved therapies; however,... 
causes of death | standardized mortality ratio | rituximab with cyclophosphamide, doxorubicin, vincristine, and prednisone (R‐CHOP) | noncancer causes of death | cure | diffuse large B‐cell lymphoma | Surveillance, Epidemiology, and End Results (SEER) | cancer‐specific survival | cancer-specific survival | diffuse large B-cell lymphoma | rituximab with cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) | UNITED-STATES | vincristine | EVENT-FREE SURVIVAL | PHASE-II | RISK | and End Results (SEER) | CHOP CHEMOTHERAPY | Epidemiology | CHEMOTHERAPY PLUS RITUXIMAB | rituximab with cyclophosphamide | TRIAL | THERAPY | Surveillance | ONCOLOGY | NON-HODGKIN-LYMPHOMA | doxorubicin | and prednisone (R-CHOP) | ELDERLY-PATIENTS | Predictive Value of Tests | Immunotherapy - methods | Age Factors | United States | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Male | Cause of Death | Neoplasm Invasiveness - pathology | Aged, 80 and over | Adult | Female | Retrospective Studies | Databases, Factual | SEER Program | Lymphoma, Large B-Cell, Diffuse - drug therapy | Lymphoma, Large B-Cell, Diffuse - pathology | Risk Assessment | Proportional Hazards Models | Combined Modality Therapy | Lymphoma, Large B-Cell, Diffuse - mortality | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Sex Factors | Survival Analysis | Aged | Neoplasm Staging | Cancer patients | Chemotherapy | Usage | Lymphocytic leukemia | Diagnosis | Health aspects | Cancer | Cell survival | Gastrointestinal tract diseases | Risk groups | Mortality | Medical services | Patients | Survival | Lymphoma | Risk factors | Diseases | Extrapolation | Demographics | Vascular diseases | Lymphocytes B | Mathematical analysis | Risk assessment | Fatalities | Lymphomas | Health risk assessment | B-cell lymphoma
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 06/2015, Volume 107, Issue 6, p. djv048
Journal Article
The Oncologist, ISSN 1083-7159, 01/2007, Volume 12, Issue 1, pp. 20 - 37
Learning Objectives After completing this course, the reader will be able to: Discuss the evolving changes in the following cancer‐related measures: median age... 
SEER | Cancer statistics | Lifetime risk | Survival | Incidence | Multiple primaries | cancer statistics | survival | RISK | BREAST-CANCER | LUNG-CANCER | RATES | WOMEN | NATION | ONCOLOGY | lifetime risk | THYROID-CANCER | multiple primaries | incidence | United States - epidemiology | SEER Program | Prevalence | Neoplasms - ethnology | United States - ethnology | Humans | Risk Factors | Female | Male | Neoplasms - diagnosis | Neoplasms - epidemiology
Journal Article